George Carman, Rutgers, The State University of New Jersey (USA)
 |
biosketch to be completed Visit his website |
Clotilde Théry, Institut Curie, Paris (France)
 |
biosketch to be completed Visit her website. |
Raphaël Rodriguez, Institut Curie, Paris (France)
 |
biosketch to be completed Visit his website. |
Eric Maréchal, Laboratoire Physiologie Cellulaire & Végétale, Grenoble (France)
 |
biosketch to be completed Visit his webpage. |
Parveen Yaqoob, University of Reading (UK)
 |
Professor Parveen Yaqoob is Deputy Vice-Chancellor and Pro-Vice-Chancellor Research and Innovation at the University of Reading, where she has worked for 27 years. Her research has focused on nutritional modulation of immune function, inflammation and vascular function, and she has a particular interest in the influence of n-3 polyunsaturated fatty acids on the generation and function of extracellular vesicles. She has contributed significantly to both national and international research funding panels for food, nutrition and health and was appointed OBE for services to higher education in 2022. Visit her website |
Richard Bazinet, Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto (Canada)
 |
Pr Richard Bazinet is a Professor and Canada Research Chair in Brain Lipid Metabolism at the University of Toronto, internationally recognized for his pioneering research into how fatty acids impact the brain. His major scientific contributions center on understanding the regulation of brain lipid metabolism, especially the roles of dietary polyunsaturated fatty acids (PUFA) like arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in neurological health. His discoveries have shed light on how these fats are metabolized in brain phospholipids and their critical involvement in neurodegenerative and neuropsychiatric disorders. Recently, Bazinet’s research demonstrated that the liver can generate palmitic acid to support brain health, and his lab’s kinetic and biochemical approaches have revealed novel mechanisms regulating fatty acid turnover and inflammation in the brain. Since 2006, he has published over 250 scientific papers cited more than 7500 times (H43) and contributed to international guidelines on dietary fats for brain health. His work influences policy and public health recommendations worldwide. He is the past-president of the International Society for the Study of Fatty Acids and Lipids, editor-in-chief of Prostaglandins, Leukotrienes and Essential Fatty Acids, and recipient of numerous prestigious awards including the Ralph Holman Lifetime Achievement Award and the Supelco AOCS Research Award for Outstanding, Original Research in Fats, Oils, Lipid chemistry or Biochemistry. Visit his website |
Rochus Benni Franke, Institute of Cellular and Molecular Botany, Bonn (Germany)
 |
Dr. Rochus Benni Franke graduated with a Diploma in Biology from the University of Kaiserslautern in Germany. In his PhD research in Dr. Heinrich Kauss’ lab in Kaiserslautern and partly in Dr. Steven Fry’s lab at University of Edinburgh he studied cell wall modifications during plant defense reactions. As a post-doc in Dr. Clint Chapple’s lab Benni chemically phenotyped new lignin-engineered plants. In a second project he identified and biochemically characterized an unaccounted enzyme in the essential phenylpropanoid pathway. As research associate at the University of Heidelberg he investigated and optimized the biosynthesis of tumor inhibiting alkaloids from cultures of medicinal plants. In 2001 he joined the Institute for Cellular and Molecular Botany at University of Bonn as assistant professor where he initiated molecular genetic research approaches in the field of plant-environment-interfaces. These pioneering analyses resulted in the identification of multiple genes in the formation of physiologically important biopolymers such as cutin, suberin and Casparian strips. Benni continued in Bonn as adjunct professor and research activities focusing on the biosynthesis of apoplastic diffusion barriers and how their chemistry affects the plants water and nutrient homeostasis and biotic interactions. Visit his webpage |
Manuel Liebeke, Max Planck Institute for Marine Microbiology, Bremen (Germany)
 |
Manuel Liebeke obtained his PhD in 2010 and went on to specialize in host–microbe interactions with a focus on microbial metabolism. Since 2024 he is a Professor for Metabolomics at Kiel University, where his lab investigates the chemical basis of microbe-host interactions using mass spectrometry imaging, fluorescence microscopy, and 3D tomography. His team develops correlative imaging workflows to spatially connect metabolite production with the anatomical and cellular context of both mutualistic and pathogenic microorganisms in animal hosts with a special focus on lipids. By integrating chemical imaging with high-resolution microscopy, his research reveals the hidden metabolic exchanges that structure host–microbe relationships in situ. Visit his website |
Christel Bergström, The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala Biomedical Center, Uppsala University (Sweden)
 |
After her PhD in 2003, Dr Bergström was employed as scientist at Department of Pharmacy, Uppsala University with the task to establish a pharmaceutical profiling laboratory. In 2009 she received an Assistant Professorship and advanced her research program to include studies of impact of formulation and physiological processing on drug solubility and absorption. This scientific edge was key to receive a Marie Curie Fellowship for international qualification (2010-2013) at Monash University (Melbourn Australia) ranked number 2 world-wide in pharmacy and pharmacology. With leading scientists at Monash University Bergström continued to develop the subject area to include computational models for matchmaking drug molecules with best performing excipients and formulations. This was a stepping stone towards obtaining an ERC Starting grant in 2015, which aimed at targeting in silico and in vitro models for better prediction and evaluation of highly complex drug delivery systems. Dr Bergström was appointed Professor in Molecular Pharmaceutics (chair) in 2020, the first female Professor in pharmaceutics in Sweden. She is nowadays an international key opinion leader within the field of drug delivery and pharmaceutics, with extensive interactions and collaborations with external stakeholders including biotech- and pharma industry, as well as hospital pharmacies. Dr. Bergström has also founded four companies and through these, she translates her knowledge and innovations, of benefits to the life science sector, patients and the society at large. Visit her website |
Claire Berton-Carabin, Laboratoire Biopolymères Interactions Assemblages, Nantes (France)
 |
biosketch to be completed Visit her website. |
